insulin in a pill, page-2

Now that's the best news I've seen in a long time!

Diabetes is a huge market, unlike most of the things these guys have launched lately.

I think sp is heading south due to the extremely poor communication from management on what's going on. I mean, why would you buy CIR at the moment? News is very infrequent, and relates to very small revenue streams. Depth is non-existent.

Current holders that are stressed may be selling out, having a huge impact on sp with very small parcels. But it will continue down until we get some significant announcements about future revenue.

Or the usual BS happens - a takeover at a 50% premium to last traded share price, which gets the all round thumbs up from the independent valuer, the board, the CEO, and everybody - except long time holders who get shafted.